During the past decade, Visioncare Research, Ltd. conducted 2 clinical trials. In the 10-year time frame, 2 clinical trials started and 2 clinical trials were completed, i.e. on average, 100% percent of trials that started reached the finish line to date. In the past 5 years, 0 clinical trials started and 1 clinical trials were completed. i.e. 0% of trials that started reached the finish line.

In terms of collaborators to trials, out of the total clinical trials conducted in "Visioncare Research, Ltd." #1 collaborator was "Visioncare Research Ltd." with 3 trials as a collaborator. Other collaborators include -1 different institutions and companies that were collaborators in the rest 1 trials.

According to Clinical.Site data, the most researched conditions in "Visioncare Research, Ltd." are "Myopia" (4 trials), "Refractive Error" (2 trials), "Astigmatism" (1 trials), "Contact Lenses" (1 trials) and "Hyperopia" (1 trials). Many other conditions were trialed in "Visioncare Research, Ltd." in a lesser frequency.

Most popular intervention types in "Visioncare Research, Ltd." are "Device" (7 trials) and "Other" (1 trials). Other intervention types were less common.

The name of intervention was led by "Clear Care cleaning and disinfecting system" (1 trials), "Comfilcon A contact lens (Biofinity)" (1 trials), "Contact lens multi-purpose solution" (1 trials), "Contact lenses" (1 trials) and "Control solution" (1 trials). Other intervention names were less common.

The vast majority of trials in "Visioncare Research, Ltd." are 7 trials for "All" genders.

Currently, there are NaN active trials in "Visioncare Research, Ltd.". undefined are not yet recruiting, undefined are recruiting, undefined are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 7 completed trials in Visioncare Research, Ltd., undefined suspended trials, and undefined terminated clinical trials to date.

Out of the total trials that were conducted in Visioncare Research, Ltd., 0 "Phase 1" clinical trials were conducted, 0 "Phase 2" clinical trials and 0 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 0 trials, and there were also 7 trials that are defined as “Not Applicable".